Neuroprotective compounds and use thereof
Provided herein are compositions and methods for reducing one or both of axonal degeneration and neuronal cell death associated with a disease or traumatic brain injury. An aminopropyl carbazole agent with potent neuroprotective properties is described. Specifically, (−)-(S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine, is proposed as a new pharmacological agent for protecting patients against axonal degeneration and chronic consequences of TBI.
1. A compound having the chemical name of (−)-(S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl-2-fluoropropyl)-6-methoxypyridin-2-amine, or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising the compound or salt of claim 1 , and a pharmaceutically acceptable carrier.
3. A method for treating a neuropsychiatric or neurodegenerative disease, comprising administering the compound or salt of claim 1 to a patient in need thereof.
4. A method of treating chronic TBI or a long-term symptom associated with TBI, comprising administering an effective amount of the compound or salt of claim 1 to a patient in need thereof.
5. The method of claim 4 , wherein the (−)-(S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine or salt is administered after an extended period following an injury, wherein the extended period is at least one month.
6. The method of claim 4 , wherein the (−)-(S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine or salt is administered for an extended period following an injury, wherein the extended period is at least one hour.